EC Number | Application | Comment | Organism |
---|---|---|---|
2.8.2.4 | medicine | diagnosis of atherosclerotic changes, enzymatic distribution and involvement in the development and pathogenesis of atherosclerosis is different between males and females | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.8.2.4 | - |
Homo sapiens |
2.8.2.15 | cDNA for isozymes STS and EST cloned | Homo sapiens |
3.1.6.2 | - |
Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.6.2 | interleukin-1beta | marked inhibition of mRNA expression and STS activity | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.8.2.4 | 3'-phosphoadenylylsulfate + estrone | Homo sapiens | - |
adenosine 3',5'-bisphosphate + estrone 3-sulfate | - |
r | |
3.1.6.2 | estrone sulfate + H2O | Homo sapiens | STS plays an important role in the in situ estrogen actions of estrogen-dependent human tissues and various sex steroid-dependent tumors, STS may be associated with the degree of atherosclerotic changes in the female aorta, transformation of the biologically inactive form of plasma estrogen in its active form | estrone + sulfate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.8.2.4 | Homo sapiens | - |
human | - |
2.8.2.15 | Homo sapiens | - |
human | - |
3.1.6.2 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.8.2.4 | abdomen | - |
Homo sapiens | - |
2.8.2.4 | aorta | female aortic smooth muscle cell line CRL-1999 cell | Homo sapiens | - |
2.8.2.4 | T/G HA-VSMC cell | - |
Homo sapiens | - |
2.8.2.15 | aorta | aortic smooth muscle cell line CRL-1999 | Homo sapiens | - |
2.8.2.15 | muscle | aortic smooth muscle cell line CRL-1999 | Homo sapiens | - |
3.1.6.2 | aorta | abdominal, STS expression levels are higher in the vascular smooth muscle cells obtained from female aortas with mild atherosclerotic changes than in those with severe atherosclerotic changes in male aortas regardless of atherosclerotic changes | Homo sapiens | - |
3.1.6.2 | additional information | not in endothelial cells or inflammatory cells including macrophages | Homo sapiens | - |
3.1.6.2 | T/G HA-VSMC cell | human female vascular smooth muscle cell line | Homo sapiens | - |
3.1.6.2 | vascular smooth muscle | STS expression levels are higher in the vascular smooth muscle cells obtained from female aortas with mild atherosclerotic changes than in those with severe atherosclerotic changes in male aortas regardless of atherosclerotic changes | Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.1.6.2 | additional information | - |
STS activities in male or female aortas with different degrees of atherosclerotic changes | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.8.2.4 | 3'-phosphoadenylylsulfate + estrone | - |
Homo sapiens | adenosine 3',5'-bisphosphate + estrone 3-sulfate | - |
r | |
3.1.6.2 | estrone sulfate + H2O | - |
Homo sapiens | estrone + sulfate | - |
? | |
3.1.6.2 | estrone sulfate + H2O | STS plays an important role in the in situ estrogen actions of estrogen-dependent human tissues and various sex steroid-dependent tumors, STS may be associated with the degree of atherosclerotic changes in the female aorta, transformation of the biologically inactive form of plasma estrogen in its active form | Homo sapiens | estrone + sulfate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.8.2.4 | EST | - |
Homo sapiens |
2.8.2.15 | steroid sulfatase | - |
Homo sapiens |
3.1.6.2 | STS | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.1.6.2 | 37 | - |
assay at | Homo sapiens |